Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 62
Filter
1.
Annals of Medicine and Surgery ; : 103662, 2022.
Article in English | ScienceDirect | ID: covidwho-1800207
2.
Neurol Res Pract ; 4(1): 10, 2022 Mar 21.
Article in English | MEDLINE | ID: covidwho-1745411

ABSTRACT

In this letter we raise several concerns regarding the interesting article by Walter and Krämer about rhomb-encephalitis as a complication two months after the vaccination with an mRNA-based SARS-CoV_2 vaccine. The causal link between the vaccination and encephalitis remained unproven, a SARS-CoV-2 infection, Bickerstaff encephalitis were not excluded, the MRI rather suggests brainstem-encephlaitis than pure rhomb-encephalitis, and the cerebro-spinal fluid was not investigated for cytokines or glial markers. Neurologists are called to make all available effort to convincingly evaluate the etiology and the pathophysiological background of an undetermined condition.

4.
PLoS One ; 17(3): e0262433, 2022.
Article in English | MEDLINE | ID: covidwho-1731594

ABSTRACT

We report strong evidence of the importance of contact hubs (or superspreaders) in mitigating the current COVID-19 pandemic. Contact hubs have a much larger number of contacts than the average in the population, and play a key role on the effectiveness of vaccination strategies. By using an age-structures compartmental SEIAHRV (Susceptible, Exposed, Infected symptomatic, Asymptomatic, Hospitalized, Recovered, Vaccinated) model, calibrated from available demographic and COVID-19 incidence, and considering separately those individuals with a much greater number of contacts than the average in the population, we show that carefully choosing who will compose the first group to be vaccinated can impact positively the total death toll and the demand for health services. This is even more relevant in countries with a lack of basic resources for proper vaccination and a significant reduction in social isolation. In order to demonstrate our approach we show the effect of hypothetical vaccination scenarios in two countries of very different scales and mitigation policies, Brazil and Portugal.


Subject(s)
COVID-19 Vaccines/administration & dosage , COVID-19/prevention & control , Models, Theoretical , Brazil , COVID-19/transmission , COVID-19/virology , Humans , Portugal , SARS-CoV-2/isolation & purification , Vaccination
5.
Rev. Soc. Bras. Med. Trop ; 55: e0381, 2022.
Article in English | WHO COVID, LILACS (Americas) | ID: covidwho-1724994
6.
Psychiatry Res Commun ; 2(1): 100029, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1706704

ABSTRACT

Infectious SARS-CoV-2 meningitis is rare, especially as the first manifestation of a SARS-CoV-2 infection. Infectious SARS-CoV-2 meningitis can initially manifest with seizures and neuropsychiatric abnormalities, worsen to the point of coma, and occasionally lead to death. Patients with infectious SARS-CoV-2 meningitis require comprehensive evaluation and forced treatment in order to improve the often poor outcome.

7.
Clinical and Experimental Neuroimmunology ; n/a(n/a), 2022.
Article in English | Wiley | ID: covidwho-1685247

ABSTRACT

-

8.
World J Virol ; 11(1): 82-84, 2022 Jan 25.
Article in English | MEDLINE | ID: covidwho-1675117

ABSTRACT

Although several considerations have been raised suggesting a beneficial effect of N-acetyl cysteine (NAC) for the treatment of severe acute respiratory syndrome coronavirus 2 infection, there is currently no clinical evidence that NAC truly prevents coronavirus disease 2019 (COVID-19), reduces the severity of the disease, or improves the outcome. Appropriately designed clinical trials are warranted to prove or disprove a therapeutic effect of NAC for COVID-19 patients.

9.
11.
American journal of physical medicine & rehabilitation ; 101(2):170-170, 2021.
Article in English | EuropePMC | ID: covidwho-1615362
12.
Clinical and Experimental Neuroimmunology ; n/a(n/a), 2022.
Article in English | Wiley | ID: covidwho-1612857

ABSTRACT

-

13.
Neurol Neurochir Pol ; 56(1): 103-104, 2022.
Article in English | MEDLINE | ID: covidwho-1593307
16.
Int J Infect Dis ; 115: 215-216, 2022 Feb.
Article in English | MEDLINE | ID: covidwho-1561567
18.
Clin Infect Dis ; 73(9): 1744, 2021 11 02.
Article in English | MEDLINE | ID: covidwho-1501058
19.
Clin Neurol Neurosurg ; : 106975, 2021 Oct 12.
Article in English | MEDLINE | ID: covidwho-1482505
SELECTION OF CITATIONS
SEARCH DETAIL